Industry-academia collaborations, seminar series by Cancer Research KI

Programme for the seminar on the 19th of May, 2022

Registration is open now

Welcome to the joint hybrid seminar between Cancer Research KI and Merck. During this seminar, you will learn how Merck is looking to expand their ongoing collaboration with KI in the areas of oncology and immuno-oncology.  An ongoing project will also be presented. There will be time to discuss and ask questions during the afternoon.  Please join either via zoom or in real life in where fika will be served before the meeting. Details obtained after the registration.

KI/Merck: existing and potential collaborations 

13.45-14.00 : Coffee and networking

14.00-14.10 : Welcome and Introduction Simon Ekman (Cancer Research KI) and Sven Pötzsch (Merck Healthcare KGaA)

14.10- 14.30 : Richard Cowburn (KI) KI perspectives on Industry/Academia Partnerships the research area of Oncology 

14.30- 14.50 : Kahina Lang (Merck Healthcare KGaA)  Strategic Innovation at Merck: Motivation and Mission

14.50- 14.55: Short break

14.55- 15.15 : Eike-Benjamin Braune (KI)  Modulation of NOTCH Signaling as a new treatment option for solid tumors

15.15- 15.35 : Felix Geist (Merck Healthcare KGaA) Identification of a NOTCH transcriptomic signature for basal like breast cancer

15.35-15.55: Simon Ekman (Cancer Research KI), Richard Cowburn (KI) and Sven Pötzsch (Merck Healthcare KGaA) Open discussion

15.55: Closing remarks Simon Ekman

Previous seminars

Programme for the seminar on January 20th, 2022

13.00 Welcoming words: Simon Ekman Leader of the Industrial collaboration working group CRKI

13.10 Why collaborate with industry? High-level examples of industrial relations KI have established within oncology: Richard Cowburn

14.00 Short break

14.10 KI processes and ways of working with industry: Richard Cowburn and External Engagement office

15.00 Conclusions and final remarks

Please register by sending an e-mail to cancerresearchKI@ki.se by Monday 17th of January